(PharmaNewsWire.Com, May 04, 2017 ) According to the report Infectious Disease Therapeutics Market, published by Market Data Forecast, the global market is projected to reach USD 132.29 Billion by 2021, at a CAGR of 7.96 % from 2016 to 2021.
Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi, parasites. These can be transmitted from one another by direct contact or indirect contact. Anti-infective drugs are used to inhibit the growth of the disease. These drugs can act through host defence system and can directly target the causative agent.
The major factors that are driving the growth of the market are increasing occurrence of infectious diseases, growing use of direct acting anti-viral, increasing health care expenditure and increasing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries. Generic erosion, Patent expiration of infectious disease drugs are the major restraints that hamper the growth of the infectious Disease Therapeutics market.
Some of the major companies dominating the global market are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Sanofi.
About us: Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
